{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:17:21Z","timestamp":1780409841902,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.msard.2022.103507","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T22:19:21Z","timestamp":1641593961000},"page":"103507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Platelet-to-lymphocyte ratio differs between MS and NMOSD at disease onset and predict disability"],"prefix":"10.1016","volume":"58","author":[{"given":"Edgar","family":"Carnero Contentti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo A.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Criniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Pettinicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Cristiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Patrucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Lazaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Fern\u00e1ndez Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Tkachuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Caride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2022.103507_bib0029","first-page":"CC01","article-title":"Relationship between neutrophil-to-lymphocyte ratio and stress in multiple sclerosis patients","volume":"11","author":"Al-Hussain","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.msard.2022.103507_bib0031","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.msard.2017.10.009","article-title":"The neutrophil-to-lymphocyte ratio as disease actvity marker in multiple sclerosis and optic neuritis","volume":"18","author":"Bisgaard","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103507_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102428","article-title":"Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice","volume":"45","author":"Carnero Contentti","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103507_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.628024","article-title":"An abnormally high neutrophil-to-lymphocyte ratio is not an independent outcome predictor in AQP4-IgG-positive NMOSD","volume":"12","author":"Carnero Contentti","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.msard.2022.103507_bib0041","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/acn3.51167","article-title":"Serum levels of cell adhesion molecules in patients with neuromyelitis optica spectrum disorder","volume":"7","author":"Chang","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2022.103507_bib0024","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2012.11.003","article-title":"Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE","volume":"42","author":"Christy","year":"2013","journal-title":"J. Autoimmun."},{"issue":"10","key":"10.1016\/j.msard.2022.103507_bib0032","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3390\/cells8101114","article-title":"The neutrophil-to-lymphocyte ratio is related to disease activity in relapsing remitting multiple sclerosis","volume":"8","author":"D\u2019Amico","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.msard.2022.103507_bib0030","first-page":"700","article-title":"The clinical significance of the neutrophil-to-lymphocyte ratio in multiple sclerosis","volume":"126","author":"Demirci","year":"2016","journal-title":"Int. J. Neurosci."},{"issue":"4","key":"10.1016\/j.msard.2022.103507_bib0011","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3343\/alm.2019.39.4.345","article-title":"The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases","volume":"39","author":"Gasparyan","year":"2019","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.msard.2022.103507_bib0036","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcma.2015.08.010","article-title":"Ak F. Is there an association between the expanded disability status scale and inflammatory markers in multiple sclerosis?","volume":"79","author":"Guzel","year":"2016","journal-title":"J. Chinese Med. Assoc."},{"issue":"4","key":"10.1016\/j.msard.2022.103507_bib0034","article-title":"The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis","volume":"4","author":"Hasselbalch","year":"2018","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"1","key":"10.1016\/j.msard.2022.103507_bib0033","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12883-019-1245-2","article-title":"The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis","volume":"19","author":"Hemond","year":"2019","journal-title":"BMC Neurol."},{"issue":"2","key":"10.1016\/j.msard.2022.103507_bib0008","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1352458515586084","article-title":"Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica","volume":"22","author":"Hertwig","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2022.103507_bib0042","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneuroim.2018.02.002","article-title":"Differentiation of remitting neuromyelitis optica spectrum disorders from multiple sclerosis by integrating parameters from serum proteins and lymphocyte subsets","volume":"318","author":"Ip","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.msard.2022.103507_bib0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.msard.2022.103507_bib0003","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jnnp-2014-308984","article-title":"Overlapping CNS inflammatory diseases: differentiating features of NMO and MS","volume":"86","author":"Jury\u0144czyk","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.msard.2022.103507_bib0002","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp-2016-313300","article-title":"Neurodegeneration in multiple sclerosis and neuromyelitis optica","volume":"88","author":"Kawachi","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"11","key":"10.1016\/j.msard.2022.103507_bib0019","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.msard.2022.103507_bib0013","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/1756-185X.13404","article-title":"Neutrophil-to-lymphocyte ratio, mean platelet volume and platelet-to-lymphocyte ratio in Beh\u00e7et\u2019s disease and their correlation with disease activity: a meta-analysis","volume":"21","author":"Lee","year":"2018","journal-title":"Int. J. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.msard.2022.103507_bib0040","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s10072-017-3068-5","article-title":"Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSD","volume":"38","author":"Lin","year":"2017","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2022.103507_bib0023","article-title":"Normal reference intervals of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and systemic immune inflammation index in healthy adults: a large multi-center study from Western China","volume":"65","author":"Luo","year":"2019","journal-title":"Clin. Lab."},{"key":"10.1016\/j.msard.2022.103507_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105949","article-title":"Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with systemic lupus erythematosus and their correlation with activity: a meta-analysis","volume":"76","author":"Ma","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.msard.2022.103507_bib0028","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.4049\/jimmunol.161.11.6421","article-title":"Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis","volume":"161","author":"McColl","year":"1998","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.msard.2022.103507_bib0035","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.3390\/ijerph18063318","article-title":"The impact of multiple sclerosis disease status and subtype on hematological profile","volume":"18","author":"Miller","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"18","key":"10.1016\/j.msard.2022.103507_bib0009","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood-2013-11-462432","article-title":"Emerging roles for platelets as immune and inflammatory cells","volume":"123","author":"Morrell","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.msard.2022.103507_bib0016","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2174\/1381612822666151209153535","article-title":"Rheumatoid arthritis: notable biomarkers linking to chronic systemic conditions and cancer","volume":"22","author":"Olumuyiwa-Akeredolu","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.msard.2022.103507_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.620963","article-title":"Platelets in multiple sclerosis: early and central mediators of inflammation and neurodegeneration and attractive targets for molecular imaging and site-directed therapy","volume":"12","author":"Orian","year":"2021","journal-title":"Front. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.msard.2022.103507_bib0001","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneuroim.2006.11.015","article-title":"Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis","volume":"184","author":"Peterson","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2022.103507_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clim.2016.06.017","article-title":"The contribution of neutrophils to CNS autoimmunity","volume":"189","author":"Pierson","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.msard.2022.103507_bib0022","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3389\/fneur.2019.01028","article-title":"AQP4 antibody assay sensitivity comparison in the era of the 2015 diagnostic criteria for NMOSD","volume":"10","author":"Prain","year":"2019","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2022.103507_bib0012","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/14397595.2015.1091136","article-title":"Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients","volume":"26","author":"Qin","year":"2016","journal-title":"Mod. Rheumatol."},{"issue":"6","key":"10.1016\/j.msard.2022.103507_bib0044","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s10072-019-04230-6","article-title":"Fern\u00e1ndez Liguori N; on behalf RelevarEM investigators. Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM)","volume":"41","author":"Rojas","year":"2020","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2022.103507_bib0026","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1084\/jem.20141015","article-title":"Neutrophil-related factors as biomarkers in EAE and MS","volume":"212","author":"Rumble","year":"2015","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.msard.2022.103507_bib0007","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ana.22686","article-title":"Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain","volume":"71","author":"Saadoun","year":"2012","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2022.103507_bib0025","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4049\/jimmunol.1400807","article-title":"Cytokine-regulated neutrophil recruitment is required for brain but not spinal cord inflammation during experimental autoimmune encephalomyelitis","volume":"193","author":"Simmons","year":"2014","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.msard.2022.103507_bib0037","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/jnen\/nly032","article-title":"Platelets drive inflammation and target gray matter and the retina in autoimmune-mediated encephalomyelitis","volume":"77","author":"Sonia D\u2019Souza","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2022.103507_bib0027","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.1202613","article-title":"Neutrophils amplify autoimmune central nervous system infiltrates by maturing local APCs","volume":"191","author":"Steinbach","year":"2013","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.msard.2022.103507_bib0015","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.3390\/jcm9092760","article-title":"The relationship between hematological markers of systemic inflammation (neutrophil-to-lymphocyte, platelet-to-lymphocyte, lymphocyte-to-monocyte ratios) and ultrasound disease activity parameters in patients with rheumatoid arthritis","volume":"9","author":"Targo\u0144ska-St\u0119pniak","year":"2020","journal-title":"J. Clin. Med."},{"issue":"10130","key":"10.1016\/j.msard.2022.103507_bib0043","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.msard.2022.103507_bib0018","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.msard.2022.103507_bib0021","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","article-title":"Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays","volume":"78","author":"Waters","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2022.103507_bib0017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.msard.2022.103507_bib0006","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3390\/jcm7120511","article-title":"The emerging role of neutrophil granulocytes in multiple sclerosis","volume":"7","author":"Woodberry","year":"2018","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.msard.2022.103507_bib0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.MIB.0000440614.83703.84","article-title":"Platelet activation and platelet-leukocyte aggregation elicited in experimental colitis are mediated by interleukin-6","volume":"20","author":"Yan","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.msard.2022.103507_bib0039","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2147\/NDT.S311942","article-title":"Neutrophil-to-lymphocyte ratio on admission is an independent risk factor for the severity of neurological impairment at disease onset in patients with a first episode of neuromyelitis optica spectrum disorder","volume":"17","author":"Zhou","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:57:18Z","timestamp":1761901038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":45,"alternative-id":["S2211034822000220"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.103507","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet-to-lymphocyte ratio differs between MS and NMOSD at disease onset and predict disability","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.103507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103507"}}